[Yeouido Investment Division 1] Seers, Inzenia Therapeutics: which stock will enter the Hall of Fame?
Predicted impact: Low
Market commentary piece with no new company facts.
Seers씨어스
458870 · KOSDAQ · ₩458870 · 씨어스
₩26,300▼ ₩1,550 (5.57%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y +3.90%
- Market cap
- ₩1T
- Enterprise value
- ₩986B
- P/E
- 24.1×
- P/B
- 14.8×
- Dividend yield
- 0.0%
- ROE
- 61.3%
- Net margin
- 43.2%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−59.1% from the high
₩19,820Today: ₩26,050 – ₩27,500₩64,234
Returns
- 1W+15.4%
- 1M+5.0%
- 3M+4.6%
- 6M−49.2%
- YTD−39.4%
- 1Y+3.9%
- Volume today
- 572,309
- 2.0× the 20-day average
- Traded today
- ₩15B
- Listed shares
- 38,345,362
- EPS (12 months)
- ₩1,092
- Earnings yield 4.2%
AI research · Update noteSeers: ₩110B Convertible Bond Fundraising Completed, Overseas Investment Phase BeginsThe completed ₩110B raise gives the company substantial funding for its overseas plans, which supports the growth story in the earlier report.Read the full report →
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
−5.6% on Oct 27, 2026. Trading value 2.1× its normal.
Seers, a Korean medical AI company, is expanding into Central Asia, introducing its AI smart ward system in Kazakhstan. Its AI monitoring system 'Think' is also being supplied to 342 beds at Ajou University Hospital through Daewoong Pharma.
AI summary of the news and filings linked. It can be wrong; check them.
- [Yeouido Investment Division 1] Seers, Inzenia Therapeutics: which stock will enter the Hall of Fame? (Money Today)
- Seers expands from Southeast Asia to Central Asia, introduces AI smart ward in Kazakhstan (Edaily)
- [BioS] Seers introduces AI medical solution to Kazakhstan's Ministry of Health (Etoday)
- Daewoong Pharma Supplies Seers' AI Monitoring System 'Think' to 342 Beds at Ajou University Hospital (Money Today)
- • Foreign investors sold a net ₩1.3B that day
- • Buzz 61 on JONBUR: heavy trading
Possible reasons, not certainties. Not financial advice.
Signals
Warming up- BuzzRisingBuzz 61: heavy trading.
- SentimentPositiveNews: Headlines report overseas expansion and a hospital supply deal, which are positive for the business. Community: 0 bullish, 0 bearish posts this week.
- MomentumFlat2.7% over the last month; the price is above its 20-day average.
- News impactHigh10 news items and filings in two weeks; 1 rated high impact, 2 medium.
Signals describe activity, not recommendations. Not financial advice.
Leveraged ETF flows
Estimated leveraged-ETF rebalance on Oct 26: sell ₩562M at the close (9.0% of 20-day average trading value)
On its 29 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 14.7% of trading value and pointed the same way 20 of 29 times.
- 2× KODEX KOSDAQ150 Leverage −₩474M
- -1× KODEX KOSDAQ150 Futures Inverse −₩39M
- 2× TIGER KOSDAQ150 Leverage −₩35M
- 2× RISE KOSDAQ150 Futures Leverage −₩10M
- -1× TIGER KOSDAQ150 Futures Inverse −₩1.1M
Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.
Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.
Estimate based on ETF size and daily moves; actual trades may differ.
ETFs holding this
All ETFs →Held by 11 funds.
- KODEX KOSDAQ1500.4%
- KODEX KOSDAQ150 Leverage2×0.4%
- TIGER KOSDAQ1500.4%
- RISE KOSDAQ1500.4%
- TIGER KOSDAQ150 Leverage2×0.4%
- ACE KOSDAQ 1500.4%
- KIWOOM KOSDAQ1500.4%
- SOL KOSDAQ1500.4%
Estimated from the funds' index or underlying stock.
Seers stock overview
Seers (씨어스, KRX: 458870) is listed on KOSDAQ, in the Medical & precision devices sector. The company provides IoMT (Internet of Medical Things) platform technology built on AI-based biosignal analysis algorithms and wearable medical devices, serving hospitals and healthcare institutions in Korea and abroad. Its shares closed at ₩26,300 on Oct 27, 2026, down 5.57% on the day, giving it a market value of ₩1T.
Key facts
- Market cap
- ₩1T
- Sector
- Medical & precision devices
- Latest price change
- −5.57%
- As of
- Oct 27, 2026
- Main business
- The company provides IoMT (Internet of Medical Things) platform technology built on AI-based biosignal analysis algorithms and wearable medical devices, serving hospitals and healthcare institutions in Korea and abroad.
Quick answers about Seers
- What does Seers do?
- The company provides IoMT (Internet of Medical Things) platform technology built on AI-based biosignal analysis algorithms and wearable medical devices, serving hospitals and healthcare institutions in Korea and abroad. Its main offerings are mobiCARE, a wearable ECG analysis service for arrhythmia screening and diagnosis sold on a subscription basis, and thynC, an inpatient monitoring solution that tracks patients' vital signs in real time on hospital wards. Its customers include medical institutions and health checkup centers across Korea, and the company is expanding into additional clinical specialties and telemonitoring.
- What is the market cap of Seers?
- The market capitalisation of Seers was ₩1T at the close on Oct 27, 2026.
- Who are the largest shareholders of Seers?
- According to the latest official filings, the largest reported holders are Lee Young-shin (29.79%, as of Aug 14, 2026); Win Best Venture Investment (4.96%, as of Oct 16, 2025); Tigris Investment (3.64%, as of Jun 24, 2025).
- When is the next earnings report from Seers?
- Korean companies rarely announce results dates in advance. Based on when Seers filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company provides IoMT (Internet of Medical Things) platform technology built on AI-based biosignal analysis algorithms and wearable medical devices, serving hospitals and healthcare institutions in Korea and abroad. Its main offerings are mobiCARE, a wearable ECG analysis service for arrhythmia screening and diagnosis sold on a subscription basis, and thynC, an inpatient monitoring solution that tracks patients' vital signs in real time on hospital wards. Its customers include medical institutions and health checkup centers across Korea, and the company is expanding into additional clinical specialties and telemonitoring.
Written by AI from the company's latest annual report.
- Korean name
- 씨어스
- CEO
- 이영신
- Founded
- Aug 2009
- Listed
- Jun 2024
- Listed shares
- 38,345,362
- Fiscal year ends
- Month 12
- Website
- seers.co.kr
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- LivsMed491000 · ₩937B₩37,100+1.50%
- SD Biosensor137310 · ₩766B₩6,340−2.01%
Recent news
Seers expands from Southeast Asia to Central Asia, introduces AI smart ward in Kazakhstan
Predicted impact: Low
Overseas expansion demonstration of AI smart ward; no size given.
[BioS] Seers introduces AI medical solution to Kazakhstan's Ministry of Health
Predicted impact: Low
Introducing AI medical solution to a foreign health ministry is an early-stage, small-impact update.
Recent filings
See all- Results of Securities Issuance (Voluntary Disclosure): 2nd Series CBOct 21, 2026
- Convertible bond issue decisionOct 13, 2026
- Investor relations (IR) eventSep 9, 2026
- Insider shareholding reportAug 14, 2026
- Insider shareholding reportAug 14, 2026
Titles in Korean until English translations are added.
Also known as: Seers / 씨어스 / 458870 / KRX:458870
Source: KRX statistical information